Celldemic is a vaccine used to protect adults and children from 6 months of age against influenza (flu) caused by the H5N1 subtype of the influenza A virus (sometimes called ‘bird flu’ or ‘avian flu’). Celldemic contains small amounts of proteins from an H5N1 strain of the influenza A virus. The virus has been inactivated so that it does not cause any disease in people who receive the vaccine.
Therapeutic Indication
### Therapeutic indication Celldemic is indicated for active immunisation against H5N1 subtype of Influenza A virus in adults and infants from 6 months of age and above. Celldemic should be used in accordance with official recommendations.
Therapeutic Area (MeSH)
ATC Code
J07BB02
ATC Item
influenza, inactivated, split virus or surface antigen
Pharmacotherapeutic Group
Vaccines
Active Substance (Summary)
INN / Common Names
| Substance | CAS | Monograph |
|---|---|---|
| Influenza virus A/turkey/Turkey/1/2005 (H5N1) NIBRG-23 strain, HA surface antigen | N/A | influenza virus a/turkey/turkey/1/2005 (h 5 n 1) nibrg-23 strain, ha surface antigen |
EMA Name
Celldemic
Medicine Name
Celldemic
Aliases
N/ANo risk management plan link.
